CASSAVA RES(00841): Possible delay in publication of annual performance

22:19 23/06/2026

Cassava Resources (00841) has announced that as of the day of this announcement, the audit of the financial statements for the year ended on March 31, 2026 has not been completed yet, as the appointment of a new auditor was only approved by the shareholders at the special general meeting held by the company on June 1, 2026.

CASSAVA RES (00841) announces that as of the date of this announcement, the audit of the financial statements for the year ended 31 March 2026 has not been completed due to the appointment of a new auditor, which was approved by the shareholders at the special general meeting held on 1 June 2026. The auditor has not identified any significant unresolved audit issues during the audit process. However, the auditor still requires more time to complete the necessary substantive audit procedures and obtain sufficient appropriate audit evidence in accordance with applicable audit standards. The board will continue to assist the auditor in completing the audit work and preliminarily expects that the annual results announcement will be made on or before 14 July 2026, and the annual report for the year ended 31 March 2026 will be sent to shareholders within four months after the end of the financial year (on or before 31 July 2026).

HK Stock Market Move | GIANT BIOGENE (02367) rose by over 4% during trading. Recently, its three categories of medical devices, including "Cross-linked Recombinant Collagen Filler", have been approved.

HK Stock Market Move | CNBM (03323) rose more than 9% in early trading, with increases in fiberglass and electronic fabric prices being smoothly passed on. Institutions point out that CNBM has a leading advantage.

Wall Street supports the technology stock pullback: Wrongly killing is a good buying opportunity, chip stocks are cooling down before the earnings report and are creating a golden opportunity.